10-K/A

AMENDMENT NO. 1 TO FORM 10-K

Company: Protalix BioTherapeutics, Inc.
Filed: July 13, 2007
Period of Report: December 31, 2006
Accession Number: 0000950136-07-004881

View Document ↗ View on SEC.gov ↗